Timing of IABP initiation and its impact on outcomes in acute myocardial infarction with cardiogenic shock: insights from a bi-center retrospective study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Influence of IABP Start Timing on Outcomes in Acute Myocardial Infarction with Cardiogenic Shock: Findings from a Bi-Center Retrospective Analysis

  • By

  • Istvan Bojti

  • Sarolta Bojtine Kovacs

  • David Kovacs

  • Antonia Ziegler

  • Alexander Maier

  • Dirk Westermann

  • Miroslaw Ferenc

  • Attila Csaba Nagy

  • Kalman Racz

  • Zsolt Koszegi

  • Gabor Tamas Szabo

  • June 8, 2026

Share

  • 1

    Cardiogenic shock (CS) has a mortality rate exceeding 40%, necessitating effective mechanical circulatory support (MCS) strategies.

  • 2

    The intra-aortic balloon pump (IABP) provides modest hemodynamic support and is the most accessible MCS modality globally.

  • 3

    Early initiation of MCS, particularly IABP, may improve survival in CS patients, but evidence on optimal timing remains insufficient.

  • 4

    This bi-center retrospective analysis investigates the impact of IABP initiation timing on outcomes in acute myocardial infarction with CS.

  • 5

    The study emphasizes the importance of the myocardial area at risk (AAR) in determining the effectiveness of MCS therapies in AMI-CS.

Original Source(s)

Related Content